What is Genworth Financial, Inc.'s earnings per share (EPS)?

Genworth Financial, Inc. (GNW) reported diluted earnings per share of $0.54 for fiscal year 2025. This represents a -20.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Genworth Financial (GNW) Financials

GNW NYSE

Trailing 12 months to June 30, 2026

Revenue $7.4B +2.1% YoY

Net Income $212.0M +12.2% YoY

EPS (Diluted) $0.53 +20.5% YoY

Operating Cash Flow $430.0M +88.6% YoY

Market Cap $3.3B as of Oct 26, 2026

Price / Sales 0.5x on $7.4B revenue, trailing 12 months to June 30, 2026

Price / Earnings 15.8x on $212.0M net income, trailing 12 months to June 30, 2026

Price / Book 0.4x on $8.7B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GNW SEC filings page.

Genworth Financial, Inc. (GNW) reported $7.4B in revenue over the twelve months to Jun 30, 2026, up 2.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GNW FY2025 2026-10-24

Genworth’s liability-funded structure produces modest earnings, while cash generation varies sharply between years.

Operating cash flow reached $327M in FY2025 versus $88M in FY2024, even as net income fell 25.4%. That divergence means annual accounting earnings are an unreliable standalone guide to the cash produced by the business.

The balance sheet is dominated by obligations rather than conventional corporate debt: liabilities represented 88.9% of assets in FY2025, while debt-to-equity was only 0.2x. With total liabilities of $78.3B against equity of $8.8B, the financing picture depends on the full liability structure, not long-term borrowings alone.

Revenue was essentially flat in FY2025, yet selling, general and administrative expense rose 3.3%; that mismatch indicates the cost base expanded faster than the business. Net profit margin finished at 3.0% after falling 1.1 percentage points, so the improvement from FY2023 remains incomplete rather than a smooth upward trend.

Financial Health Signals

Financial Health Score (5 of 6 dimensions) 19/100

Scored as: Insurers peer group

Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Genworth Financial, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Loss Ratio

Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Genworth Financial, Inc. scores 4/100 on it among other insurers.

Premium Growth

Genworth Financial, Inc. reported revenue of $7.3B in fiscal year 2025, against $7.3B in fiscal year 2024. Premium Growth ranks insurers on the three-year path of the premiums they write rather than on total revenue, and Genworth Financial, Inc. scores 16/100 among other insurers.

Capital

Genworth Financial, Inc. funded 9.9% of its assets with shareholders' equity at the end of fiscal year 2025, holding $8.8B of equity against $88.1B of assets. Capital ranks insurers on that cushion, and Genworth Financial, Inc. scores 20/100 among other insurers.

Investment Yield

n/a

Not available for Genworth Financial, Inc., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.

Combined Ratio

Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Genworth Financial, Inc. scores 9/100 on it among other insurers.

Stability

Genworth Financial, Inc. reported net income of $223.0M in fiscal year 2025, against $299.0M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Genworth Financial, Inc. scores 46/100 among other insurers.

Piotroski F-Score Partial

5/7

Genworth Financial, Inc. passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.9B

YoY+5.8%

QoQ+7.0%

5Y CAGR-1.4%

10Y CAGR-1.6%

Genworth Financial, Inc. generated $1.9B in revenue in Q2 2026. This represents an increase of 5.8% from the same quarter a year earlier. Against the prior quarter it is up 7.0%.

Net Income

$47.0M

YoY-7.8%

QoQ0.0%

5Y CAGR-27.8%

10Y CAGR-12.2%

Genworth Financial, Inc. reported $47.0M in net income in Q2 2026. This represents a decrease of 7.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

EPS (Diluted)

$0.12

YoY0.0%

QoQ0.0%

Genworth Financial, Inc. earned $0.12 per diluted share (EPS) in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt

$2.0B

YoY+10.5%

QoQ-6.3%

5Y CAGR-2.2%

10Y CAGR-5.4%

Genworth Financial, Inc. held $2.0B in cash against $1.5B in long-term debt as of Q2 2026.

Shares Outstanding

378M

YoY-7.9%

QoQ-1.3%

Genworth Financial, Inc. had 378M shares outstanding in Q2 2026. This represents a decrease of 7.9% from the same quarter a year earlier. Against the prior quarter it is down 1.3%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Net Margin

2.5%

YoY-0.4pp

QoQ-0.2pp

5Y change-9.3pp

10Y change-5.2pp

Genworth Financial, Inc.'s net profit margin was 2.5% in Q2 2026, showing the share of revenue converted to profit. This is down 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.

Return on Equity

0.5%

YoY0.0pp

QoQ0.0pp

5Y change-1.0pp

10Y change-0.6pp

Genworth Financial, Inc.'s quarterly ROE was 0.5% in Q2 2026: one quarter's net income over shareholder equity, not annualized. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$63.0M

YoY+96.9%

QoQ-6.0%

Genworth Financial, Inc. spent $63.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 96.9% from the same quarter a year earlier. Against the prior quarter it is down 6.0%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

GNW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GNW quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$7.4B	$7.3B+0.1%	$7.3B-2.6%	$7.5B-0.1%	$7.5B-4.2%	$7.8B-5.6%	$8.3B+7.5%	$7.7B-2.5%	$7.9B+5.2%	$7.5B-10.2%	$8.4B-2.1%	$8.5B-2.1%	$8.7B+1.2%	$8.6B-10.5%	$9.6B-2.9%	$9.9B
SG&A Expenses	$1.0B	$1.0B+3.3%	$977.0M+3.7%	$942.0M-26.7%	$1.3B+28.8%	$998.0M+6.7%	$935.0M+2.9%	$909.0M-3.6%	$943.0M-1.5%	$957.0M-24.8%	$1.3B-2.8%	$1.3B+15.0%	$1.1B-8.5%	$1.2B-22.0%	$1.6B-17.4%	$1.9B
Operating Income	N/A	N/A	N/A	$41.0M-95.0%	$818.0M+72.6%	$474.0M+52.9%	$310.0M-12.7%	$355.0Mn/m	-$5.0M-100.9%	$530.0Mn/m	-$316.0M-223.9%	$255.0Mn/m	-$398.0M-168.0%	$585.0M+45.2%	$403.0M+646.3%	$54.0M
EBITDA	N/A	N/A	N/A	$305.0M-73.3%	$1.1B+33.3%	$858.0M+11.0%	$773.0M+1.3%	$763.0M+122.4%	$343.0M-62.8%	$922.0M+406.6%	$182.0M-85.1%	$1.2B+2120.0%	$55.0M	N/A	N/A	N/A
Interest Expense	$104.0M	$105.0M-8.7%	$115.0M-2.5%	$118.0M+11.3%	$106.0M-33.8%	$160.0M-17.9%	$195.0M-15.6%	$231.0M-9.8%	$256.0M-3.8%	$266.0M-21.1%	$337.0M-19.6%	$419.0M-3.2%	$433.0M-3.8%	$450.0M-5.5%	$476.0M-5.9%	$506.0M
Income Tax	$70.0M	$84.0M-46.8%	$158.0M+51.9%	$104.0M-67.4%	$319.0M+28.6%	$248.0M+7.8%	$230.0M+65.5%	$139.0M+98.6%	$70.0Mn/m	-$406.0M-213.4%	$358.0Mn/m	-$9.0Mn/m	-$94.0M-130.0%	$313.0M+126.8%	$138.0Mn/m	-$11.0M
Net Income	$212.0M	$223.0M-25.4%	$299.0M+293.4%	$76.0M-91.7%	$916.0M+7.8%	$850.0M+377.5%	$178.0M-48.1%	$343.0M+188.2%	$119.0M-85.4%	$817.0Mn/m	-$277.0Mn/m	-$615.0Mn/m	-$1.2B-322.1%	$560.0M+72.3%	$325.0M+755.3%	$38.0M
EPS (Basic)	N/A	$0.54-21.7%	$0.69+331.2%	$0.16-91.2%	$1.82+8.3%	$1.68+380.0%	$0.35-48.5%	$0.68+183.3%	$0.24-85.4%	$1.64n/m	-$0.56n/m	-$1.24n/m	-$2.51-322.1%	$1.13+71.2%	$0.66+725.0%	$0.08
EPS (Diluted)	$0.53	$0.54-20.6%	$0.68+325.0%	$0.16-91.1%	$1.79+8.5%	$1.65+371.4%	$0.35-47.8%	$0.67+179.2%	$0.24-85.3%	$1.63n/m	-$0.56n/m	-$1.24n/m	-$2.51-324.1%	$1.12+69.7%	$0.66+725.0%	$0.08
Diluted Shares (Avg)	N/A	414M-5.8%	439M-7.5%	475M-7.0%	511M-0.7%	515M+0.6%	512M+0.4%	510M+1.9%	500M-0.2%	501M+0.6%	498M+0.2%	497M+0.2%	496M-0.5%	499M+0.9%	494M+0.2%	494M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$1.9B+5.8%	$1.8B-0.5%	$1.8B+0.1%	$1.9B+2.9%	$1.8B+1.5%	$1.8B-4.2%	$1.8B-6.8%	$1.9B+2.7%
SG&A Expenses	$268.0M+7.6%	$213.0M-9.7%	$265.0M+4.7%	$259.0M0.0%	$249.0M+8.7%	$236.0M0.0%	$253.0M	$259.0M+13.6%
Operating Income	N/A	N/A	N/A	N/A	$68.0M-45.6%	$51.0M-40.0%	N/A	$48.0M+14.3%
EBITDA	N/A	N/A	N/A	N/A	$125.0M-32.4%	$111.0M-26.0%	N/A	$110.0M+2.8%
Interest Expense	$26.0M0.0%	$25.0M-3.8%	$26.0M-3.7%	$27.0M-3.6%	$26.0M-13.3%	$26.0M-13.3%	$27.0M	$28.0M-6.7%
Income Tax	$26.0M-25.7%	$31.0M-13.9%	$4.0M-80.0%	$9.0M-77.5%	$35.0M+9.4%	$36.0M-45.5%	$20.0M	$40.0M+33.3%
Net Income	$47.0M-7.8%	$47.0M-13.0%	$2.0Mn/m	$116.0M+36.5%	$51.0M-32.9%	$54.0M-61.2%	-$1.0Mn/m	$85.0M+193.1%
EPS (Basic)	$0.120.0%	$0.12-7.7%	$0.00n/m	$0.29+45.0%	$0.12-29.4%	$0.13-58.1%	$0.00n/m	$0.20+233.3%
EPS (Diluted)	$0.120.0%	$0.12-7.7%	$0.01n/m	$0.28+47.4%	$0.12-29.4%	$0.13-58.1%	$0.00n/m	$0.19+216.7%
Diluted Shares (Avg)	386M-7.5%	394M-6.9%	N/A	413M-5.2%	418M-5.3%	423M-6.1%	N/A	436M-6.5%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

GNW Balance Sheet

GNW quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$88.1B+1.5%	$86.8B-4.4%	$90.8B+1.2%	$89.7B-9.5%	$99.2B-6.2%	$105.7B+4.3%	$101.3B+0.4%	$100.9B-4.2%	$105.3B+0.6%	$104.7B-1.7%	$106.4B-4.4%	$111.3B+3.0%	$108.0B-4.6%	$113.3B+1.0%	$112.2B
Cash & Equivalents	$2.0B-0.6%	$2.0B-7.5%	$2.2B+23.1%	$1.8B+14.5%	$1.6B+52.2%	$1.0B-68.4%	$3.3B+65.2%	$2.0B-31.3%	$2.9B+3.3%	$2.8B-53.3%	$6.0B+28.4%	$4.6B+27.0%	$3.7B+0.7%	$3.6B-18.3%	$4.4B
Short-Term Investments	$37.0M+825.0%	$4.0M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$14.0M0.0%	$14.0M-12.5%	$16.0M-98.2%	$867.0M-0.1%	$868.0M-9.4%	$958.0M
Total Liabilities	$78.3B+1.1%	$77.4B-6.1%	$82.5B+1.4%	$81.3B-1.9%	$82.9B-7.8%	$89.9B+3.7%	$86.7B0.0%	$86.7B-3.6%	$90.0B-0.2%	$90.2B-1.7%	$91.8B-2.9%	$94.5B+2.3%	$92.4B-3.3%	$95.5B-0.5%	$96.1B
Long-Term Debt	$1.5B-0.3%	$1.5B-4.2%	$1.6B-1.7%	$1.6B-15.2%	$1.9B-44.2%	$3.4B+3.8%	$3.3B-11.6%	$3.7B-12.2%	$4.2B+1.1%	$4.2B-8.5%	$4.6B-0.9%	$4.6B-10.6%	$5.2B+8.1%	$4.8B+1.1%	$4.7B
Total Equity	$8.8B+3.6%	$8.4B+12.9%	$7.5B-2.0%	$7.6B-50.8%	$15.5B+1.3%	$15.3B+8.0%	$14.2B+13.9%	$12.4B-7.2%	$13.4B+6.1%	$12.6B-1.4%	$12.8B-14.1%	$14.9B+3.7%	$14.4B-12.7%	$16.5B+9.8%	$15.0B
Retained Earnings	$1.7B+15.2%	$1.5B+20.5%	$1.2B+6.5%	$1.1B-54.3%	$2.5B+57.2%	$1.6B+8.4%	$1.5B+30.7%	$1.1B+0.4%	$1.1B+287.8%	$287.0M-49.1%	$564.0M-52.2%	$1.2B-51.3%	$2.4B+30.1%	$1.9B+21.1%	$1.5B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$87.4B0.0%	$86.8B-0.6%	$88.1B+1.5%	$88.5B-2.5%	$87.3B-0.2%	$87.3B-2.2%	$86.8B-4.4%	$90.8B+6.2%
Cash & Equivalents	$2.0B+10.5%	$2.1B+12.1%	$2.0B-0.6%	$2.0B-1.0%	$1.8B-7.0%	$1.9B-3.1%	$2.0B-7.5%	$2.1B+3.2%
Short-Term Investments	$79.0M	$29.0M	$37.0M+825.0%	$26.0M	N/A	N/A	$4.0M	N/A
Total Liabilities	$77.6B+0.1%	$76.9B-0.8%	$78.3B+1.1%	$78.7B-3.5%	$77.6B-0.8%	$77.6B-3.4%	$77.4B-6.1%	$81.5B+6.4%
Long-Term Debt	$1.5B-1.3%	$1.5B-0.7%	$1.5B-0.3%	$1.5B-1.8%	$1.5B-2.8%	$1.5B-3.8%	$1.5B-4.2%	$1.5B-3.4%
Total Equity	$8.7B-0.7%	$8.8B+1.2%	$8.8B+3.6%	$8.8B+6.0%	$8.8B+3.9%	$8.7B+8.8%	$8.4B+12.9%	$8.3B+3.2%
Retained Earnings	$1.8B+10.0%	$1.7B+10.6%	$1.7B+15.2%	$1.7B+14.5%	$1.6B+13.1%	$1.6B+15.8%	$1.5B+20.5%	$1.5B+6.0%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.

GNW Cash Flow Statement

GNW quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$430.0M	$327.0M+271.6%	$88.0M-85.3%	$597.0M-43.1%	$1.0B+140.0%	$437.0M-77.7%	$2.0B-5.7%	$2.1B+27.3%	$1.6B-36.1%	$2.6B+36.4%	$1.9B+17.7%	$1.6B-34.7%	$2.4B+74.3%	$1.4B+45.4%	$962.0M-69.2%	$3.1B
Depreciation & Amortization	N/A	$231.0M-7.2%	$249.0M-5.7%	$264.0M-19.0%	$326.0M-15.1%	$384.0M-17.1%	$463.0M+13.5%	$408.0M+17.2%	$348.0M-11.2%	$392.0M-21.3%	$498.0M-48.4%	$966.0M+113.2%	$453.0M	N/A	N/A	N/A
Stock-Based Compensation	N/A	$58.0M+13.7%	$51.0M+4.1%	$49.0M+32.4%	$37.0M-7.5%	$40.0M+2.6%	$39.0M+50.0%	$26.0M-25.7%	$35.0M+12.9%	$31.0M-3.1%	$32.0M+100.0%	$16.0M-42.9%	$28.0M-28.2%	$39.0M+50.0%	$26.0M-16.1%	$31.0M
Investing Cash Flow	$181.0M	$518.0M-39.8%	$861.0M-31.7%	$1.3B+72.0%	$733.0M-18.2%	$896.0Mn/m	-$1.2B-188.6%	$1.3Bn/m	-$622.0Mn/m	-$759.0Mn/m	-$2.1Bn/m	-$404.0Mn/m	-$1.8Bn/m	-$580.0Mn/m	-$722.0Mn/m	-$59.0M
Financing Cash Flow	-$422.0M	-$857.0Mn/m	-$1.1Bn/m	-$1.4Bn/m	-$1.6Bn/m	-$2.4Bn/m	-$1.5Bn/m	-$2.2Bn/m	-$1.6Bn/m	-$1.8Bn/m	-$3.0Bn/m	-$42.0M-120.5%	$205.0Mn/m	-$149.0Mn/m	-$1.1Bn/m	-$1.6B
Share Buybacks	$300.0M	$247.0M+30.7%	$189.0M-36.1%	$296.0M+362.5%	$64.0Mn/m	$0n/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$52.0M+766.7%	$91.0M+167.6%	$200.0M+640.7%	$87.0M-46.0%	$6.0M-14.3%	$34.0Mn/m	$27.0M-81.6%	$161.0M-8.0%
Depreciation & Amortization	$54.0M-5.3%	$55.0M-8.3%	$57.0M-8.1%	$57.0M-8.1%	$57.0M-5.0%	$60.0M-7.7%	$62.0M-1.6%	$62.0M-4.6%
Stock-Based Compensation	N/A	$15.0M+36.4%	N/A	N/A	N/A	$11.0M-21.4%	N/A	N/A
Investing Cash Flow	-$172.0M-198.9%	-$5.0Mn/m	$50.0M-77.3%	$308.0M+28.3%	$174.0M-32.6%	-$14.0M-109.8%	$220.0M-36.8%	$240.0Mn/m
Financing Cash Flow	-$14.0Mn/m	-$2.0Mn/m	-$250.0Mn/m	-$156.0Mn/m	-$274.0Mn/m	-$177.0Mn/m	-$255.0Mn/m	-$276.0Mn/m
Share Buybacks	$63.0M+96.9%	$67.0M+48.9%	$96.0M+77.8%	$74.0M+105.6%	$32.0M-11.1%	$45.0M-28.6%	$54.0M+54.3%	$36.0M-55.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid.

GNW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GNW quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	N/A	N/A	0.5%-10.4pp	10.9%+4.9pp	6.1%+2.3pp	3.7%-0.9pp	4.6%+4.7pp	-0.1%-7.1pp	7.0%+10.8pp	-3.8%-6.8pp	3.0%+7.5pp	-4.6%-11.3pp	6.8%+2.6pp	4.2%+3.6pp	0.5%
Net Margin	3.0%-1.1pp	4.1%+3.1pp	1.0%-11.2pp	12.2%+1.3pp	10.9%+8.7pp	2.1%-2.3pp	4.5%+2.9pp	1.5%-9.4pp	10.9%+14.2pp	-3.3%+3.9pp	-7.2%+7.1pp	-14.2%-20.7pp	6.5%+3.1pp	3.4%+3.0pp	0.4%
Return on Equity	2.5%-1.0pp	3.5%+2.5pp	1.0%-11.0pp	12.0%+6.5pp	5.5%+4.3pp	1.2%-1.3pp	2.4%+1.5pp	1.0%-5.1pp	6.1%+8.3pp	-2.2%+2.6pp	-4.8%+3.5pp	-8.3%-12.2pp	3.9%+1.9pp	2.0%+1.7pp	0.3%
Return on Assets	0.3%-0.1pp	0.3%+0.3pp	0.1%-0.9pp	1.0%+0.2pp	0.9%+0.7pp	0.2%-0.2pp	0.3%+0.2pp	0.1%-0.7pp	0.8%+1.0pp	-0.3%+0.3pp	-0.6%+0.5pp	-1.1%-1.6pp	0.5%+0.2pp	0.3%+0.3pp	0.0%
Debt-to-Equity	0.170.0x	0.180.0x	0.210.0x	0.21+0.1x	0.12-0.1x	0.220.0x	0.23-0.1x	0.300.0x	0.310.0x	0.330.0x	0.360.0x	0.310.0x	0.36+0.1x	0.290.0x	0.31
Liabilities-to-Equity	8.95-0.2x	9.17-1.9x	11.03+0.4x	10.66+5.3x	5.35-0.5x	5.87-0.2x	6.11-0.9x	6.97+0.3x	6.71-0.4x	7.130.0x	7.16+0.8x	6.33-0.1x	6.42+0.6x	5.79-0.6x	6.39
Asset Turnover	0.080.0x	0.080.0x	0.080.0x	0.080.0x	0.080.0x	0.080.0x	0.080.0x	0.080.0x	0.070.0x	0.080.0x	0.080.0x	0.080.0x	0.080.0x	0.090.0x	0.09

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	N/A	N/A	N/A	N/A	3.8%-3.3pp	2.9%-1.7pp	N/A	2.5%+0.3pp
Net Margin	2.5%-0.4pp	2.6%-0.4pp	0.1%+0.2pp	6.0%+1.5pp	2.8%-1.5pp	3.0%-4.4pp	-0.1%+11.0pp	4.5%+2.9pp
Return on Equity	0.5%0.0pp	0.5%-0.1pp	0.0%0.0pp	1.3%+0.3pp	0.6%-0.3pp	0.6%-1.1pp	0.0%+2.8pp	1.0%+0.7pp
Return on Assets	0.1%0.0pp	0.1%0.0pp	0.0%0.0pp	0.1%0.0pp	0.1%0.0pp	0.1%-0.1pp	0.0%+0.2pp	0.1%+0.1pp
Debt-to-Equity	0.170.0x	0.170.0x	0.170.0x	0.170.0x	0.170.0x	0.170.0x	0.180.0x	0.190.0x
Liabilities-to-Equity	8.89+0.1x	8.73-0.2x	8.95-0.2x	8.93-0.9x	8.83-0.4x	8.91-1.1x	9.17-1.9x	9.81+0.3x
Asset Turnover	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x

Not reported in any period shown, so not listed: Gross Margin, Current Ratio, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Genworth Financial, Inc. GNW	FY2025	$7.3B	$223.0M	3.0%	$3.3B	19/100
Brighthouse Financial, Inc. BHF	FY2025	$6.8B	$433.0M	6.4%	$2.6B	8/100
F&G Annuities & Life, Inc. FG	FY2025	$5.7B	$265.0M	4.6%	$2.7B	27/100
CNO Financial Group, Inc. CNO	FY2025	$4.5B	$229.3M	5.1%	$5.0B	32/100
Lincoln National Corp. LNC	FY2025	$18.2B	$1.2B	6.5%	$7.7B	27/100
Jackson Financial Inc. JXN	FY2025	$6.7B	$27.0M	0.4%	$9.0B	11/100

Where Genworth Financial, Inc. Ranks

Frequently Asked Questions

What is Genworth Financial, Inc.'s annual revenue?

Genworth Financial, Inc. (GNW) reported $7.3B in total revenue for fiscal year 2025. This represents a 0.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Genworth Financial, Inc.'s revenue growing?

Genworth Financial, Inc. (GNW) revenue grew by 0.1% year-over-year, from $7.3B to $7.3B in fiscal year 2025.

Is Genworth Financial, Inc. profitable?

Yes, Genworth Financial, Inc. (GNW) reported a net income of $212.0M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net income of $223.0M, with a net profit margin of 3.0%.

How much debt does Genworth Financial, Inc. have?

As of fiscal year 2025, Genworth Financial, Inc. (GNW) had $2.0B in cash and equivalents against $1.5B in long-term debt.

What is Genworth Financial, Inc.'s net profit margin?

Genworth Financial, Inc. (GNW) had a net profit margin of 3.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Genworth Financial, Inc.'s return on equity (ROE)?

Genworth Financial, Inc. (GNW) has a return on equity of 2.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Genworth Financial, Inc.'s operating cash flow?

Genworth Financial, Inc. (GNW) generated $327.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Genworth Financial, Inc.'s total assets?

Genworth Financial, Inc. (GNW) had $88.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Does Genworth Financial, Inc. buy back shares?

Yes, Genworth Financial, Inc. (GNW) spent $247.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Genworth Financial, Inc. have outstanding?

Genworth Financial, Inc. (GNW) had 388M shares outstanding as of fiscal year 2025.

What is Genworth Financial, Inc.'s debt-to-equity ratio?

Genworth Financial, Inc. (GNW) had a debt-to-equity ratio of 0.17 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Genworth Financial, Inc.'s liabilities-to-equity ratio?

Genworth Financial, Inc. (GNW) had a liabilities-to-equity ratio of 8.95 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Genworth Financial, Inc.'s return on assets (ROA)?

Genworth Financial, Inc. (GNW) had a return on assets of 0.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Genworth Financial, Inc.'s P/E ratio?

Genworth Financial, Inc. (GNW) trades at 15.8x earnings, its market capitalization divided by $212.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.3B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Genworth Financial, Inc.'s price-to-sales ratio?

Genworth Financial, Inc. (GNW) trades at 0.5x sales, its market capitalization divided by $7.4B revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.3B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Genworth Financial, Inc.'s Piotroski F-Score?

Genworth Financial, Inc. (GNW) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

How financially healthy is Genworth Financial, Inc.?

Genworth Financial, Inc. (GNW) scores 19 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is the average of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Genworth Financial, Inc. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.